-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2025.
- OnKure Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2025 was -175 %, a 499% decline year-over-year.
- OnKure Therapeutics, Inc. annual Return On Equity for 2024 was 79.2 %.
- OnKure Therapeutics, Inc. annual Return On Equity for 2023 was -60.7 %, a 7.39% increase from 2022.
- OnKure Therapeutics, Inc. annual Return On Equity for 2022 was -65.5 %, a 74% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)